During the EMT process, cancer cells withdraw the epithelial markers (such as occludin and E-cadherin) and express mesenchymal markers (fibronectin, vimentin, and N-cadherin), which make the cancer cells mobile and disease aggressive [38]. The gene discussed is CDH1; the disease is cancer.